PhoreMost

Through its SITESEEKER® drug target identification platform, PhoreMost is expanding druggable space.

Latest funding

$12M Series B+ · September 10, 2024

Led by Parkwalk Advisors · Source: startupintros.com

Total raised: $72M across 3 sourced rounds

All 4 rounds ↓

Website: phoremost.com.

X: @PhoreMostLtd · 641 followers.

LinkedIn: linkedin.com.

Category: Health and bio.

Sectors: Biopharma, Biotechnology, Health Care.

Stage: Series B+.

Based in: Cambridge, United Kingdom.

Total raised: $72M in 3 sourced rounds.

Last round: Sep 10, 2024 · 793 days ago.

Headcount: 11–50 employees.

On Recent Funding since: Nov 8, 2026.

Signals

X account@PhoreMostLtd · created Jan 25, 2017 (9 years old) · 641 followers

Website registeredJan 20, 2014 (12 years old)

About PhoreMost

In partnership, we are discovering and developing the …

TIMELINE · MONEY RAISED

PhoreMost | 442 days from website to first raise on record

@PhoreMostLtd·Raised $72M in 3 sourced rounds·1 signal before the first raise

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

September 10, 2024
Series B+ · $12M
PParkwalk Advisors (lead), AAmadeus Capital Partners, AAstellas Venture Management, BBusiness Growth Fund, JJonathan Milner
Source: startupintros.com
March 1, 2021
Series B+ · $45M
BBusiness Growth Fund (lead), AAstellas Venture Management, JJonathan Milner, MMorningside, OO2h Ventures, PParkwalk Advisors, TTrend Investment Group, XXtalPi
Source: startupintros.com
May 1, 2018
Series A · $15M
AAmadeus Capital Partners (lead), JJonathan Milner (lead), PParkwalk Advisors (lead), UUniversity of Cambridge Enterprise (lead)
Source: startupintros.com
January 25, 2017
X account created
April 7, 2015
Seed · amount undisclosed
AAmadeus Capital Partners, JJonathan Milner, PParkwalk Advisors, PPrashant Shah, SSunil Shah
Source: finsmes.com
January 20, 2014
Website created

Founders and team

AV
Ashok Venkitaraman Founder
CT
Chris Torrance Founder
AK
Alastair Kilgour Non Executive Director
GF
Gabriel Fox Chief Medical Officer
NT
Neil Torbett Chief Executive Officer

Investors

Companies like PhoreMost

EElucidata$16M Series A · Sep 2022
33T Biosciences$40M Series A · Aug 2022
CCrossbow Therapeutics$77M Series B+ · Mar 2026
WWonderTxPre Seed · Sep 2026
EExo Therapeutics$78M Series B+ · Oct 2021
OOna Therapeutics$86.6M Series B+ · Oct 2026

Other companies backed by Parkwalk Advisors

Aadsilico$13.35M Series A · Oct 2026
BBibli U$55M Series B+ · Jun 2026
QQuantum Motion$160M Series B+ · May 2026
IImmutrin$86.45M Series A · Mar 2026
BBrainomix$25.4M Series B+ · Feb 2026
PPhasecraft$34M Series B+ · Oct 2025

Parkwalk Advisors portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/phoremost-limited (get a free API key).